期刊文献+

慢性肾炎系膜细胞周期调控蛋白P27的表达与病理分级及疗效关系 被引量:14

Relationship Between Pathological Classifications,Treatment Results And P27 of Cell-cycle Regulatory Proteins In Chronic Glomerulonephritis
下载PDF
导出
摘要 目的 :探讨慢性肾炎患者肾小球系膜细胞周期调控蛋白P2 7的表达与病理分级、疗效的关系。方法 :对 32例慢性肾炎患者进行肾活检 ,将标本分别行常规病理检查及P2 7、PCNA免疫组化检查。结果 :Ⅰ级病理损害 ,P2 7表达最高 ;Ⅲ级病理损害 ,PCNA表达最高。P2 7、P2 7/PCNA比值与病理分级的等级相关分析 ,其r =- 0 .5 72 9(负相关 ) ,其r =- 0 .6 984(负相关 ) ;病理分级、P2 7/PCNA比值与疗效的等级相关分析 ,其r值分别 =0 .5 75 5 (正相关 )、0 .6 95 8(正相关 ) ;所有的r值 (P <0 .0 1)。结论 :P2 7、PCNA作为判断慢性肾炎的系膜细胞是处于增殖或抑制状态 。 Objective: To explore the relationship among pathological classification,treatment results and P27 of cell-cycle regulatory proteins in chronic glomerulonephritis(CGN).Methods: Apply renal biopsy to 32 cases of CGN and the specimen of renal biopsy had been examined with the method of pathological routing and immunohistochemistry such as P27 and PCNA.Results: The expression of P27 was the highest in class I of pathological damage but PCNA in class Ⅲ.The rankred correlation analysis between P27 and Pathological classifications was negative (r=-0.5729) while that between P27/PCNA and pathological classifications was negative(r=-0.6984);The ranked correlations analysis between treatment results and P27 was positive (r=0.6174)While that between treatment resulte and P27/PCNA was positive (r=0.6958);All the value of r less than 0.01.Conclusion: The proliferation or inhibition of mesangial cell in CGN can be judged by the testing of P27 and PCNA.This method is practical.
出处 《中国中西医结合肾病杂志》 2001年第4期211-213,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 慢性肾炎 P27蛋白 PCNA 病理分级 chronic glomerulonephritis P27 PCNA pathological classification
  • 相关文献

参考文献5

  • 1张明,郭慕依,张秀荣,金惠铭.肾小球系膜增生机制的免疫组化研究[J].中华肾脏病杂志,1995,11(4):208-211. 被引量:16
  • 2朱彤莹.肾脏疾病中细胞周期调控研究进展[J].国外医学(泌尿系统分册),1999,19(2):76-79. 被引量:3
  • 3Kurki P, Vanderlaan M, Grary DJ, et al. Expression of proliferating cell nuclear antigen(PCAN)/cyclin during the cell cyclin. Exp Cell Res, 1986,166: 209. 被引量:1
  • 4Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism,tumrigenesis, and female sterility in P27 ( Kipl )-deficient mice. Cell, 1996,85:733-744. 被引量:1
  • 5Shankland SJ, Hugo C, Coats SR, et al. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. kidney Int, 1996,50:1230-1239. 被引量:1

二级参考文献1

  • 1郭慕依,肾脏病与透析肾移植杂志,1993年,2卷,2期,168页 被引量:1

共引文献16

同被引文献79

  • 1张明,郭慕依,张秀荣,金惠铭.肾小球系膜增生机制的免疫组化研究[J].中华肾脏病杂志,1995,11(4):208-211. 被引量:16
  • 2谢文光,魏钰书,王会信,周良玉,周承富,蒋滋慧.活血化瘀中药的纤溶和纤溶抑制作用[J].中国医药学报,1996,11(6):18-21. 被引量:35
  • 3印会河.中医基础理论[M].上海:上海科学技术出版社,1983.52. 被引量:13
  • 4Shimizu A, Kitamura H, Masuda Y, et al. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int, 1995,47 : 114 - 121. 被引量:1
  • 5Wang X, Gorospe M, Huang Y, et al. P27^kipl overexpression causes apoptotic death of mammalian cells. Oncogene, 1997, 15(24) :2991 - 2997. 被引量:1
  • 6Takemura T, Murakami K, Miyazato H, et al. Expression of Fas antigen and Bcl - 2 in human glomerulonephritis. Kidney Int, 1995,48(6) : 1886 - 1892. 被引量:1
  • 7Miret C, Font J, Molina R, et al. Relationship of oncogenes (sFas, Bcl - 2) and cytokines ( IL - 10, alfa - TNF) with the activity of systemic lupus erythematosus. Anticancer Res, 2001,21(4B) :3053 - 3094. 被引量:1
  • 8Jodo S, Kobayashi S, Kayagaki N, et al. Serum levels of solu ble Fas/APO- 1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE)and other autoirnmune diseases. Clin Exp Irnmunol, 1997, 107:89 - 95. 被引量:1
  • 9Tanaka M, Itai T, Adachi M, et al. Downregulation of Fas ligand by shedding. Nat Med, 1998,4 : 31 - 36. 被引量:1
  • 10Schneider P, Holler N, Bodmer JL, et al. Conversion of membrane- bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med, 1998,187:1205 - 1213. 被引量:1

引证文献14

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部